非典型阿尔茨海默病纵向临床衰退的异质性及神经解剖相关因素研究
本研究比较了非典型阿尔茨海默病中logopenic型进行性失语(LPA)与后皮质萎缩(PCA)变异型的纵向临床变化速率,并采用主成分分析评估变化模式的异质性及其与脑萎缩的关系。结果显示LPA在命名、复述、工作记忆和言语情景记忆上衰退更快,PCA在视空间和知觉功能上衰退更快;临床衰退模式高度异质,与不同区域萎缩模式相关,PCA病程较LPA进展更慢。
要点
- LPA患者基线表现更差且命名、复述、工作记忆及言语情景记忆衰退更快。
- PCA患者基线视空间和知觉功能及临床痴呆评定量表更差,视知觉功能衰退更快。
- 临床衰退模式高度异质,需10个主成分解释>90%方差,第一主成分与左颞顶叶萎缩相关。
核心结论
- LPA与PCA的纵向临床衰退模式不同且高度异质,并与不同的地形扩散模式相关;PCA较LPA进展更慢。
研究设计与样本
- 病例对照设计,纳入28例PCA和27例LPA患者,均 amyloid 和 tau AD 生物标志物阳性,并接受系列神经科和神经心理学评估及结构MRI。
- 比较13项临床指标的変化速率,采用主成分分析评估临床变化模式,并与基于张量形态测量的区域脑萎缩速率相关。
主要发现
- LPA较PCA基线表现更差且命名、复述、工作记忆及言语情景记忆衰退更快。
- PCA较LPA基线视空间和知觉功能及临床痴呆评定量表更差,视知觉功能衰退更快。
- 主成分分析显示临床衰退模式高度异质,需10个主成分解释>90%方差;第一主成分反映整体严重度,LPA评分高于PCA反映LPA衰退更快,并与左颞顶叶萎缩相关。
- 第二和第三主成分与临床表型无关,但与区域萎缩有一定关系。
- 主成分与年龄、性别、病程、amyloid PET结果或载脂蛋白基因型无关联。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: The aims of this work were to compare rates of longitudinal change in neurologic and neuropsychological test performance between the logopenic progressive aphasia (LPA) and posterior cortical atrophy (PCA) variants of atypical Alzheimer disease (AD) and to use unbiased principal component analysis to assess heterogeneity in patterns of change and relationships to demographics and concurrent brain atrophy. METHODS: Patients with PCA or LPA who were positive for amyloid and tau AD biomarkers and had undergone serial neurologic and neuropsychological assessments and structural MRI were identified. Rates of change in 13 clinical measures were compared between groups in a case-control design, and principal component analysis was used to assess patterns of clinical change unbiased by clinical phenotype. Components were correlated with rates of regional brain atrophy with tensor-based morphometry. RESULTS: Twenty-eight patients with PCA and 27 patients with LPA were identified. Those with LPA showed worse baseline performance and faster rates of decline in naming, repetition, and working memory, as well as faster rates of decline in verbal episodic memory, compared to those with PCA. Conversely, patients with PCA showed worse baseline performance in tests of visuospatial and perceptual function and on the Clinical Dementia Rating Scale and faster rates of decline in visuoperceptual function compared to those with LPA. Principal component analysis showed that patterns of clinical decline were highly heterogeneous across the cohort, with 10 principal components required to explain >90% of the variance. The first principal component reflected overall severity, with higher scores in LPA than PCA reflecting faster decline in LPA, and was related to left temporoparietal atrophy. The second and third principal components were not related to clinical phenotype but showed some relationship to regional atrophy. No relationships were identified between the principal components and age, sex, disease duration, amyloid PET findings, or apolipoprotein genotype. DISCUSSION: Longitudinal patterns of clinical decline differ between LPA and PCA but are heterogeneous and related to different patterns of topographic spread. PCA is associated with a more slowly progressive course than LPA.
引用
- Whitwell JL, Martin PR, Graff-Radford J, et al. Investigating Heterogeneity and Neuroanatomic Correlates of Longitudinal Clinical Decline in Atypical Alzheimer Disease. Neurology. 2022. PMID: 35483899. doi:10.1212/WNL.0000000000200336
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。